báo cáo hóa học: Emerging concepts in biomarker discovery; The US-Japan workshop on immunological molecular markers in oncology

Tuyển tập các báo cáo nghiên cứu về hóa học được đăng trên tạp chí sinh học quốc tế đề tài : Emerging concepts in biomarker discovery; The US-Japan workshop on immunological molecular markers in oncology
Nội dung trích xuất từ tài liệu:
báo cáo hóa học:" Emerging concepts in biomarker discovery; The US-Japan workshop on immunological molecular markers in oncology"Journal of Translational Medicine BioMed Central Open AccessCommentaryEmerging concepts in biomarker discovery; The US-Japanworkshop on immunological molecular markers in oncologyHideaki Tahara*1, Marimo Sato*1, Magdalena Thurin*2, Ena Wang*3,Lisa H Butterfield*4, Mary L Disis5, Bernard A Fox6, Peter P Lee7,Samir N Khleif8, Jon M Wigginton9, Stefan Ambs10, Yasunori Akutsu11,Damien Chaussabel12, Yuichiro Doki13, Oleg Eremin14,Wolf Hervé Fridman15, Yoshihiko Hirohashi16, Kohzoh Imai16,James Jacobson2, Masahisa Jinushi1, Akira Kanamoto1, Mohammed Kashani-Sabet17, Kazunori Kato18, Yutaka Kawakami19, John M Kirkwood4,Thomas O Kleen20, Paul V Lehmann20, Lance Liotta21, Michael T Lotze22,Michele Maio23,24, Anatoli Malyguine25, Giuseppe Masucci26,Hisahiro Matsubara11, Shawmarie Mayrand-Chung27, Kiminori Nakamura18,Hiroyoshi Nishikawa28, A Karolina Palucka12, Emanuel F Petricoin21,Zoltan Pos3, Antoni Ribas29, Licia Rivoltini30, Noriyuki Sato31,Hiroshi Shiku28, Craig L Slingluff32, Howard Streicher33, David F Stroncek34,Hiroya Takeuchi35, Minoru Toyota36, Hisashi Wada13, Xifeng Wu37,Julia Wulfkuhle21, Tomonori Yaguchi19, Benjamin Zeskind38,Yingdong Zhao39, Mai-Britt Zocca40 and Francesco M Marincola*3Address: 1Department of Surgery and Bioengineering, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo,Tokyo, Japan, 2Cancer Diagnosis Program, National Cancer Institute (NCI), National Institutes of Health (NIH), Rockville, Maryland, 20852, USA,3Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center and Center for HumanImmunology (CHI), NIH, Bethesda, Maryland, 20892, USA, 4Departments of Medicine, Surgery and Immunology, Division of HematologyOncology, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, 15213, USA, 5Tumor Vaccine Group, Center for TranslationalMedicine in Womens Health, University of Washington, Seattle, Washington, 98195, USA, 6Earle A Chiles Research Institute, Robert W FranzResearch Center, Providence Portland Medical Center, and Department of Molecular Microbiology and Immunology, Oregon Health and ScienceUniversity, Portland, Oregon, 97213, USA, 7Department of Medicine, Division of Hematology, Stanford University, Stanford, California, 94305,USA, 8Cancer Vaccine Section, NCI, NIH, Bethesda, Maryland, 20892, USA, 9Discovery Medicine-Oncology, Bristol-Myers Squibb Inc., Princeton,New Jersey, USA, 10Laboratory of Human Carcinogenesis, Center of Cancer Research, NCI, NIH, Bethesda, Maryland, 20892, USA, 11Departmentof Frontier Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan, 12Baylor Institute for Immunology Research and Baylor ResearchInstitute, Dallas, Texas, 75204, USA, 13Department of Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan, 14Section of Surgery,Biomedical Research Unit, Nottingham Digestive Disease Centre, University of Nottingham, NG7 2UH, UK, 15Centre de la Reserche des Cordeliers,INSERM, Paris Descarte University, 75270 Paris, France, 16Sapporo Medical University, School of Medicine, Sapporo, Japan, 17Melanoma Clinic,University of California, San Francisco, California, USA, 18Department of Molecular Medicine, Sapporo Medical University, School of Medicine,Sapporo, Japan, 19Division of Cellular Signaling, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, Japan,20Cellular Technology Ltd, Shaker Heights, Ohio, 44122, USA, 21Department of Molecular Pathology and Microbiology, Center for AppliedProteomics and Molecular Medicine, George Mason University, Manassas, Virginia, 10900, USA, 22Illman Cancer Center, University of Pittsburgh,Pittsburgh, Pennsylvania, 15213, USA, 23Medical Oncology and Immunotherapy, Department. of Oncology, University, Hospital of Siena, IstitutoToscano Tumori, Siena, Italy, 24Cancer Bioimmunotherapy Unit, Department of Medical Oncology, Centro di Riferimento Oncologico, IRCCS,Aviano, 53100, Italy, 25Laboratory of Cell Mediated Immunity, SAIC-Frederick, Inc. NCI-Frederick, Frederick, Maryland, 21702, USA,26Department of Oncology-Pathology, Karolinska Institute, Stockholm, 171 76, Sweden, 27The Biomarkers Consortium (BC), Public-PrivatePartnership Program, Office of the Director, NIH, Bethesda, Maryland, 20892, USA, 28Department of Cancer Vaccine, Department of Immuno-gene Therapy, Mie University Graduate School of Medicine, Mie, Japan, 29Department of Medicine, Jonsson Comprehensive Cancer Center, UCLA,Los Angeles, California, 90095, USA, 30Unit ...